RESEARCH • VALIDATION • PATIENT SAFETY

CLINICAL EVIDENCE.
MEASURABLE RESULTS.

Explore published research, hospital studies, laboratory validation and safety guidance addressing mattress contamination, healthcare- associated infections and the performance of the Soteria® Bed Barrier.

EVIDENCE AT A GLANCE

48%
REPORTED REDUCTION

C. difficile infections in an Indiana hospital study.

>99.9999%
MICROBIAL REDUCTION

Reported in validation of the commercial laundering process.

72%
MATTRESS DAMAGE

Reported during a five-hospital mattress audit.

WHY THE MATTRESS MATTERS

THE PATIENT SURFACE IS PART OF THE INFECTION-PREVENTION ENVIRONMENT.

Research and safety guidance have identified challenges involving mattress contamination, damaged covers, cleaning effectiveness and the potential for residual biological material to remain within healthcare mattresses.

CONTAMINATION

Studies have evaluated contamination remaining on mattresses and bed components following routine terminal cleaning.

MATTRESS INTEGRITY

Hospital audits have documented damaged mattress covers and staining within mattress cores.

VALIDATED PROTECTION

Soteria studies have evaluated infection outcomes, barrier performance and validated laundering.

SELECTED CLINICAL EVIDENCE

PUBLISHED FINDINGS & HOSPITAL EXPERIENCE.

Each summary below is paired with the underlying publication, presentation or research source so the evidence can be reviewed directly.

RANDOMIZED STUDY <1 LOG

REDUCTION ACHIEVED DURING TERMINAL CLEANING

MATTRESS & BED CONTAMINATION

Evaluation of a launderable bed protection system for hospital beds

A randomized study in a 66-bed Indiana hospital examined mattress and bed-deck contamination. The study found less than a 1-log reduction during the terminal cleaning process and reported that mattresses and bed decks protected by the barrier did not become contaminated after barrier removal at patient discharge.

Antimicrobial Resistance & Infection Control, 2012

VIEW THE PUBLISHED STUDY →
LAUNDRY VALIDATION >99.9999%

REDUCTION OF TESTED BACTERIA & SPORES

VALIDATED REPROCESSING

Successful removal of C. difficile spores and pathogenic bacteria

Commercial laundering of the barrier was evaluated using heavy soil conditions including blood and urine. Testing included C. difficile spores and multiple pathogenic bacterial organisms.

Therapeutic Advances in Infectious Disease, 2020

VIEW THE PUBLISHED STUDY →
FIVE-HOSPITAL AUDIT 72%

OF MATTRESSES
REPORTED DAMAGED

MATTRESS INTEGRITY

Hospital mattress failures: a hidden patient danger

A five-hospital audit evaluated mattress condition and identified extensive mattress-cover failures. The report also documented widespread staining within a substantial number of mattress cores.

Infection Control & Hospital Epidemiology, 2021

VIEW THE PUBLISHED STUDY →
KENTUCKY HOSPITAL 43%

REPORTED REDUCTION
IN C. DIFFICILE INFECTIONS

HEALTHCARE-ASSOCIATED INFECTIONS

Launderable bed barrier and antibiotic stewardship in an acute-care hospital

A pre-post hospital study evaluated implementation of a launderable bed barrier alongside antibiotic stewardship and reported a 43% reduction in hospital-onset C. difficile infections.

Journal of Health Economics and Outcomes Research, 2019

VIEW THE STUDY →
VIRGINIA HOSPITAL NO

INCREASE IN
SKIN INJURIES

WOUND CARE & PATIENT SAFETY

Wounds, C. difficile and a mattress cover

A WOCN conference presentation described reductions in C. difficile and wound infections after implementation while reporting no increase in pressure-related injuries.

WOCN Conference Poster Presentation, 2018

VIEW THE PRESENTATION →

ADDITIONAL FINDINGS

EVIDENCE ACROSS INFECTION PREVENTION, UTILIZATION & PATIENT SAFETY.

34%

REDUCTION IN PSEUDOMONAS-RELATED DAKIN’S UTILIZATION

An Indiana hospital analysis reported a 34% reduction in Dakin’s solution utilization during the study period.

VIEW POSTER →
60%

GREATER CHANCE OF HOCDI AFTER EXPOSURE

A SHEA poster presentation reported increased risk of hospital-onset C. difficile infection when the previous occupant of the same bed had CDI.

VIEW SHEA POSTER →
71%

REDUCTION IN HOCDI REPORTED IN VIRGINIA PRESENTATION

A Virginia Patient Safety Summit presentation described improvement following bed-frame replacement and further improvement following implementation of a bed barrier.

VIEW PRESENTATION →

SAFETY GUIDANCE

MATTRESS SAFETY HAS DRAWN NATIONAL ATTENTION.

Independent safety organizations and regulators have issued guidance addressing damaged mattress covers, retained fluids and the importance of mattress inspection and maintenance.

#2

ECRI 2019 TOP TEN HEALTH TECHNOLOGY HAZARDS

Clean mattresses can retain blood and body fluids.

ECRI identified mattress contamination among its 2019 Top Ten Health Technology Hazards.

FDA

FDA SAFETY GUIDANCE

Covers for hospital bed mattresses: learn how to keep them safe.

FDA guidance encourages healthcare facilities to inspect mattress covers and remove or replace damaged surfaces in accordance with manufacturer instructions.

VIEW FDA GUIDANCE →

CONFERENCE PRESENTATIONS

ADDITIONAL RESEARCH & PRESENTATIONS.

Explore supporting conference material examining hospital mattresses, contamination and healthcare-associated infection.

SHEA • 2022

Impact of exposure to potentially contaminated hospital beds on risk of HOCDI

VIEW PRESENTATION →

FROM EVIDENCE TO ACTION

A DIFFERENT APPROACH TO THE PATIENT MATTRESS.

Soteria® Bed Barrier provides a removable, launderable protective layer between the patient and the mattress, supported by a validated reprocessing process.

Study summaries are provided for informational purposes. Results reflect the specific studies, institutions, populations and methodologies referenced. Follow the source links above to review the original research and supporting materials.